Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
4 pending office actions • 2 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
New York University In Abu Dhabi Corporation is currently managing 4 pending office actions in the Medical Devices & Mechanical Engineering technology area. These actions are distributed across 4 distinct examiners and 2 distinct art units. Daniel C Chappell is the busiest examiner, managing 1 pending office action. This distribution indicates that each pending action is being handled by a different examiner, requiring the university to navigate multiple individual examination styles.
The concentration of 4 pending actions within 2 distinct art units suggests that the university's research and patenting efforts are focused on specific technical domains. With 4 distinct examiners involved, the university is interacting with a diverse set of officials despite the limited number of art units. This structure may require managing multiple distinct prosecution timelines simultaneously. The fact that no examiner handles more than 1 pending action suggests a highly decentralized review process for the university's current patent applications.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| §103 only | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHAPPELL, DANIEL C | 1 | 80.8% | +45.8% |
| SUN, CHARLIE | 1 | 91.3% | +11.5% |
| KHANDKER, RAIHAN R | 1 | 64.2% | +57.2% |
| GREENE, IVAN A | 1 | 18.7% | +6.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18553986 | IN VIVO ORAL INSULIN DELIVERY VIA COVALENT ORGANIC FRAMEWORKS | GREENE, IVAN A | 66d overdue |
| 18908407 | SYSTEM, METHOD AND COMPUTER-ACCESSIBLE MEDIUM FOR A ZERO-COPY DATA-COHERENT SHARED-MEMORY INTER-PROCESS COMMUNICATION SYSTEM | CHAPPELL, DANIEL C | — |
| 18887264 | SYSTEM, METHOD AND COMPUTER-ACCESSIBLE MEDIUM FOR AN INTER-PROCESS COMMUNICATION TOOLS COUPLING SYSTEM | SUN, CHARLIE | — |
| 18707382 | DRUG ELUTING NERVE GUIDE CONDUIT | KHANDKER, RAIHAN R | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18908407 | SYSTEM, METHOD AND COMPUTER-ACCESSIBLE MEDIUM FOR A ZERO-COPY DATA-COHERENT SHARED-MEMORY INTER-PROCESS COMMUNICATION SYSTEM | CHAPPELL, DANIEL C | — |
| 18887264 | SYSTEM, METHOD AND COMPUTER-ACCESSIBLE MEDIUM FOR AN INTER-PROCESS COMMUNICATION TOOLS COUPLING SYSTEM | SUN, CHARLIE | — |
| 18707382 | DRUG ELUTING NERVE GUIDE CONDUIT | KHANDKER, RAIHAN R | — |
| Art Unit | Apps |
|---|---|
| 3771 | 1 |
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18908407 | SYSTEM, METHOD AND COMPUTER-ACCESSIBLE MEDIUM FOR A ZERO-COPY DATA-COHERENT SHARED-MEMORY INTER-PROCESS COMMUNICATION SYSTEM | CHAPPELL, DANIEL C | — | §102§103 | Non-Final OA | — | Pending | Oct 07, 2024 |
| 18887264 | SYSTEM, METHOD AND COMPUTER-ACCESSIBLE MEDIUM FOR AN INTER-PROCESS COMMUNICATION TOOLS COUPLING SYSTEM | SUN, CHARLIE | — | §101§102§103 | Non-Final OA | — | Pending | Sep 17, 2024 |
| 18707382 | DRUG ELUTING NERVE GUIDE CONDUIT | KHANDKER, RAIHAN R | 3771 | §102§103 | Final Rejection | — | Pending | May 03, 2024 |
| 18553986 | IN VIVO ORAL INSULIN DELIVERY VIA COVALENT ORGANIC FRAMEWORKS | GREENE, IVAN A | 1619 | §103 | Final Rejection | 66d overdue | Pending | Oct 04, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial